2019
DOI: 10.1016/j.jsat.2019.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
55
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(63 citation statements)
references
References 20 publications
1
55
0
Order By: Relevance
“…The inpatient healthcare system was ill-prepared for the rapid influx of patients who have OUD, who often present with medical complexities, co-morbid psychiatric disease, and have an increased risk of experiencing poverty, homelessness and other socio-economic barriers to health. People who have a substance use disorder (SUD) encounter stigma in the medical system reflective of a broader culture that has historically criminalized drug use and framed addiction not as a disease, but as a choice [7,8]. The direct consequences of stigma include: delay of medical care, nondisclosure of risky behaviors, rushed visits, downplaying pain, avoidance of harm reduction services (such as needle exchange programs) and decreased drug treatment completion [911].…”
Section: Introductionmentioning
confidence: 99%
“…The inpatient healthcare system was ill-prepared for the rapid influx of patients who have OUD, who often present with medical complexities, co-morbid psychiatric disease, and have an increased risk of experiencing poverty, homelessness and other socio-economic barriers to health. People who have a substance use disorder (SUD) encounter stigma in the medical system reflective of a broader culture that has historically criminalized drug use and framed addiction not as a disease, but as a choice [7,8]. The direct consequences of stigma include: delay of medical care, nondisclosure of risky behaviors, rushed visits, downplaying pain, avoidance of harm reduction services (such as needle exchange programs) and decreased drug treatment completion [911].…”
Section: Introductionmentioning
confidence: 99%
“…These lessons also apply to the care of patients who require prolonged hospitalization for other reasons. For example, individuals with serious, injection-related infections are expected to abstain from using substances or risk increased stigma, scrutiny, confiscation of substances and syringes, and even refusal of care ( Bearnot, Mitton, Hayden, & Park, 2019 ). Instead of optimizing safety within these clinical settings, the abstinence-focused perspectives that are pervasive within many large medical institutions establish hospitals as “risk environment[s]” in which people who use drugs face limited choices and constrained abilities to maintain their health and well-being ( McNeil, Small, Wood, & Kerr, 2014 ).…”
mentioning
confidence: 99%
“…We found that despite reports of stigmatization of people who inject drugs [7], patients with IDU-SAB received all of the appropriate ID-related interventions, which were associated with improvements in mortality [3, 6]. However, this care broke down for those who left AMA, none of whom received intravenous or oral antibiotics or medical follow-up.…”
Section: Discussionmentioning
confidence: 95%